{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:30:49Z","timestamp":1792783849712,"version":"4.5.0"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Commission with the project \u201cInformation network on rare cancers\u201d","award":["2000111201"],"award-info":[{"award-number":["2000111201"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.critrevonc.2017.01.019","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T10:44:37Z","timestamp":1486982677000},"page":"136-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":169,"special_numbering":"C","title":["Mucosal melanoma of the head and neck"],"prefix":"10.1016","volume":"112","author":[{"given":"Paolo Antonio","family":"Ascierto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Accorona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Botti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Gogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Maroldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ravanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Vanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2017.01.019_bib0005","series-title":"Il follow up. Milano","author":"AIOM","year":"2014"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2017.01.019_bib0010","first-page":"6","article-title":"Oral amelanotic melanoma","volume":"17","author":"Adisa","year":"2012","journal-title":"Ann. Ib Postgrad. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jop.12235","article-title":"Immunohistochemical profile of oral mucosal and head and neck cutaneous melanoma","volume":"44","author":"Alaeddini","year":"2015","journal-title":"J. Oral Pathol. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(13)70024-X","article-title":"MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study","volume":"14","author":"Ascierto","year":"2013","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.01.019_bib0025","first-page":"434","article-title":"Epidemiologic study of excessive oral melanin pigmentation with special reference to the influence of tobacco habits","volume":"90","author":"Axell","year":"1982","journal-title":"Scand. J. Dent. Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2017.01.019_bib0030","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/hed.20878","article-title":"Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital","volume":"30","author":"Bachar","year":"2008","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.critrevonc.2017.01.019_bib0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9610(70)80001-0","article-title":"Malignant melanoma of the skin of the head and neck. An analysis of 405 cases","volume":"120","author":"Ballantyne","year":"1970","journal-title":"Am. J. Surg."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.01.019_bib0040","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/jclinpath-2013-201471","article-title":"Molecular biology of normal melanocytes and melanoma cells","volume":"66","author":"Bandarchi","year":"2013","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/RLU.0b013e31815c5092","article-title":"Radioguided surgical strategy in mucosal melanoma of the nasal cavity","volume":"33","author":"Baptista","year":"2008","journal-title":"Clin. Nucl. Med."},{"issue":"21","key":"10.1016\/j.critrevonc.2017.01.019_bib0050","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","article-title":"KIT gene mutations and copy number in melanoma subtypes","volume":"14","author":"Beadling","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.01.019_bib0055","doi-asserted-by":"crossref","first-page":"e567","DOI":"10.1097\/SCS.0000000000001165","article-title":"Primary malignant mucosal melanoma of the nasopharynx: an unusual cause of unilateral hearing loss","volume":"25","author":"Bekci","year":"2014","journal-title":"J. Craniofac. Surg."},{"issue":"12","key":"10.1016\/j.critrevonc.2017.01.019_bib0060","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archoto.2010.217","article-title":"Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study","volume":"136","author":"Benlyazid","year":"2010","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.hoc.2009.03.005","article-title":"Applications of genomics in melanoma oncogene discovery","volume":"23","author":"Berger","year":"2009","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.01.019_bib0070","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/DAD.0b013e318276cab3","article-title":"Adhesion molecules in primary oral mucosal melanoma: study of claudins, integrins and immunoglobulins in a series of 35 cases","volume":"35","author":"Bologna","year":"2013","journal-title":"Am. J. Dermatopathol."},{"issue":"22","key":"10.1016\/j.critrevonc.2017.01.019_bib0075","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1001\/jama.2011.746","article-title":"KIT as a therapeutic target in metastatic melanoma","volume":"305","author":"Carvajal","year":"2011","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.critrevonc.2017.01.019_bib0080","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1002\/lary.23625","article-title":"Mucosal melanoma of the head and neck: 32-year experience in a tertiary referral hospital","volume":"122","author":"Chan","year":"2012","journal-title":"Laryngoscope"},{"issue":"26","key":"10.1016\/j.critrevonc.2017.01.019_bib0085","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.01.019_bib0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S0022215110002720","article-title":"Malignant melanoma of nasal cavity and paranasal sinuses: report of 24 patients and literature review","volume":"125","author":"Clifton","year":"2011","journal-title":"J. Laryngol. Otol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00066-007-1616-2","article-title":"Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses","volume":"183","author":"Combs","year":"2007","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.critrevonc.2017.01.019_bib0100","article-title":"Head and Neck: primary oral mucosal melanoma","author":"Coutinho-Camillo","year":"2015","journal-title":"Atlas Genet. Cytogenet. Oncol. Haematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.01.019_bib0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/DAD.0b013e31819cd0cb","article-title":"Stem cells for epidermal melanocytes\u2013a challenge for students of dermatopathology","volume":"31","author":"Cramer","year":"2009","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.critrevonc.2017.01.019_bib0110","doi-asserted-by":"crossref","first-page":"432479","DOI":"10.1155\/2015\/432479","article-title":"Intratumoral heterogeneity of MAGE-C1\/CT7 and MAGE-C2\/CT10 expression in mucosal melanoma","volume":"2015","author":"Curioni-Fontecedro","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"20","key":"10.1016\/j.critrevonc.2017.01.019_bib0115","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.critrevonc.2017.01.019_bib0120","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejca.2013.09.007","article-title":"Efficacy and safety of ipilimumab 3mg\/kg in patients with pretreated: metastatic, mucosal melanoma","volume":"50","author":"Del Vecchio","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00066-013-0489-9","article-title":"Niwa Y, et al. Particle therapy for mucosal melanoma of the head and neck. A single-institution retrospective comparison of proton and carbon ion therapy","volume":"190","author":"Demizu","year":"2014","journal-title":"Strahlenther. Onkol."},{"issue":"20","key":"10.1016\/j.critrevonc.2017.01.019_bib0135","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1038\/sj.onc.1206460","article-title":"Development of melanocyte precursors from the vertebrate neural crest","volume":"22","author":"Dupin","year":"2003","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.critrevonc.2017.01.019_bib0140","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1470-2045(15)70122-1","article-title":"Adjuvant ipilimumab versus placebo after complete resectionof high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial","volume":"16","author":"Eggermont","year":"2015","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.01.019_bib0145","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1080\/15384047.2015.1030546","article-title":"c-Myc modulation: a key role in melanoma drug response","volume":"16","author":"Fico","year":"2015","journal-title":"Cancer Biol. Ther."},{"issue":"22","key":"10.1016\/j.critrevonc.2017.01.019_bib0150","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1088\/0031-9155\/57\/22\/7543","article-title":"Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy","volume":"57","author":"Fossati","year":"2012","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.critrevonc.2017.01.019_bib0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1748-717X-9-162","article-title":"High-dose proton beam therapy for sinonasal mucosal malignant melanoma","volume":"9","author":"Fuji","year":"2014","journal-title":"Radiat. Oncol."},{"issue":"13","key":"10.1016\/j.critrevonc.2017.01.019_bib0160","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S1470-2045(15)00307-1","article-title":"PD-L1 expression as a potential predictive biomarker","volume":"16","author":"Fusi","year":"2015","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.01.019_bib0165","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/lary.21925","article-title":"Demographics and treatment trends in sinonasal mucosal melanoma","volume":"121","author":"Gal","year":"2011","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.01.019_bib0170","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/annonc\/mdn001","article-title":"Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis","volume":"19","author":"Garbe","year":"2008","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.01.019_bib0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/CMR.0b013e3283470ffd","article-title":"Review: mucosal melanoma of the head and neck","volume":"21","author":"Gavriel","year":"2011","journal-title":"Melanoma Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.01.019_bib0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.anorl.2013.11.004","article-title":"Mucosal melanoma of the nasal cavity and paranasal sinuses","volume":"131","author":"Gilain","year":"2014","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."},{"issue":"768","key":"10.1016\/j.critrevonc.2017.01.019_bib0185","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1259\/0007-1285-64-768-1147","article-title":"Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses","volume":"64","author":"Gilligan","year":"1991","journal-title":"Br. J. Radiol."},{"issue":"11","key":"10.1016\/j.critrevonc.2017.01.019_bib0190","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1128\/JCM.01635-08","article-title":"DNA from BK virus and JC virus and from KI, WU, and MC polyomaviruses as well as from simian virus 40 is not detected in non-UV-light-associated primary malignant melanomas of mucous membranes","volume":"46","author":"Giraud","year":"2008","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0195","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00428-006-0167-8","article-title":"Anatomic site-specific patterns of gene copy number gains in skin: mucosal, and uveal melanomas detected by fluorescence in situ hybridization","volume":"449","author":"Glatz-Krieger","year":"2006","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0200","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1148\/radiology.158.2.3941871","article-title":"Choroidal melanomas: correlation of NMR spectroscopy and MR imaging","volume":"158","author":"Gomori","year":"1986","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2017.01.019_bib0205","series-title":"AJCC Cancer Staging Manual","year":"2002"},{"issue":"21","key":"10.1016\/j.critrevonc.2017.01.019_bib0210","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1200\/JCO.2010.33.9275","article-title":"Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification","volume":"29","author":"Guo","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0215","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ijc.21366","article-title":"Comprehensive analysis of the p53 status in mucosal and cutaneous melanomas","volume":"118","author":"Gwosdz","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2017.01.019_bib0220","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archoto.2009.173","article-title":"Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results","volume":"135","author":"Hanna","year":"2009","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"7","key":"10.1016\/j.critrevonc.2017.01.019_bib0225","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0360-3016(82)90058-X","article-title":"Radiotherapy for mucosal melanoma","volume":"8","author":"Harwood","year":"1982","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9839","key":"10.1016\/j.critrevonc.2017.01.019_bib0230","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.critrevonc.2017.01.019_bib0235","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/hed.21651","article-title":"Sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green in cutaneous head and neck\/lip mucosa melanomas","volume":"34","author":"Hayashi","year":"2012","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0240","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1368-8375(99)00085-8","article-title":"Oral mucosal melanoma: epidemiology and pathobiology","volume":"36","author":"Hicks","year":"2000","journal-title":"Oral Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.01.019_bib0245","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.critrevonc.2017.01.019_bib0250","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2012.47.7836","article-title":"Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal: acral, and chronically sun-damaged skin","volume":"31","author":"Hodi","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0255","first-page":"9","article-title":"Malignant melanomas of the nasal cavity after occupational exposure to formaldehyde","volume":"48","author":"Holmstrom","year":"1991","journal-title":"Br. J. Ind. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0260","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/DAD.0b013e31825fa1f6","article-title":"The CDKN2A and MAP kinase pathways: molecular roads to primary oral mucosal melanoma","volume":"35","author":"Hsieh","year":"2013","journal-title":"Am. J. Dermatopathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0265","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4193\/Rhin12.075","article-title":"Primary sinonasal malignant melanoma: a nationwide study of the Swedish population, 1960-2000","volume":"51","author":"Jangard","year":"2013","journal-title":"Rhinology"},{"issue":"10","key":"10.1016\/j.critrevonc.2017.01.019_bib0270","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1245\/s10434-011-1685-4","article-title":"Predictors of survival in mucosal melanoma of the head and neck","volume":"18","author":"Jethanamest","year":"2011","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0275","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.radonc.2010.09.017","article-title":"Malignant mucosal melanoma treated with carbon ion radiotherapy with concurrent chemotherapy: prognostic value of pretreatment apparent diffusion coefficient (ADC)","volume":"98","author":"Jingu","year":"2011","journal-title":"Radiother. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.01.019_bib0280","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tripleo.2005.01.018","article-title":"Transformation of a benign oral pigmentation to primary oral melanoma","volume":"100","author":"Kahn","year":"2005","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.01.019_bib0285","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/ajot.2000.18865","article-title":"Malignant melanoma of the sinonasal cavity: explanation of magnetic resonance signal intensities with histopathologic characteristics","volume":"21","author":"Kim","year":"2000","journal-title":"Am. J. Otolaryngol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.01.019_bib0290","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3342\/ceo.2008.1.4.206","article-title":"Ki67 antigen as a predictive factor for prognosis of sinonasal mucosal melanoma","volume":"1","author":"Kim","year":"2008","journal-title":"Clin. Exp. Otorhinolaryngol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0295","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.01.019_bib0300","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1200\/JCO.2001.19.9.2370","article-title":"High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH\/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694\/S9512\/C509801","volume":"19","author":"Kirkwood","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.01.019_bib0305","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/lary.23343","article-title":"Accuracy of the current TNM classification in predicting survival in patients with sinonasal mucosal melanoma","volume":"122","author":"Koivunen","year":"2012","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0310","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ijrobp.2006.01.016","article-title":"Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A Rare Cancer Network study","volume":"65","author":"Krengli","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0315","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hed.23872","article-title":"Update on primary head and neck mucosal melanoma","volume":"38","author":"L\u00f3pez","year":"2016","journal-title":"Head Neck"},{"issue":"20","key":"10.1016\/j.critrevonc.2017.01.019_bib0320","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","article-title":"Combined vemurafenib and cobimetinib in BRAF-mutated melanoma","volume":"371","author":"Larkin","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2017.01.019_bib0325","series-title":"Presented at Society for Melanoma Research (SMR) 2015 International Congress; November 18\u201321","article-title":"Efficacy and safety of Nivolumab (NIVO) monotherapy in the treatment of advanced mucosal melanoma (MEL)","author":"Larkin","year":"2015"},{"issue":"Suppl. 9","key":"10.1016\/j.critrevonc.2017.01.019_bib0330","article-title":"Ipilimumab (IPI) Expanded Access Program (EAP) for patients (pts) with Stage III\/IV melanoma: safety data by subgroups","volume":"23","author":"Lawrence","year":"2012","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.01.019_bib0335","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ijrobp.2014.03.042","article-title":"Mucosal melanoma of the head and neck: a systematic review of the literature","volume":"90","author":"Lazarev","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5s Suppl","key":"10.1016\/j.critrevonc.2017.01.019_bib0340","article-title":"Phase II multicentric uncontrolled national trial assessing the efficacy of nilotinib in the treatment of advanced melanomas with c-KIT mutation or amplification","volume":"32","author":"Lebbe","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0345","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00405-014-3119-y","article-title":"Surgical management of recurrent sinonasal mucosal melanoma: endoscopic or transfacial resection","volume":"272","author":"Ledderose","year":"2014","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0350","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1288\/00005537-199402000-00001","article-title":"Mucosal melanoma of the head and neck: the impact of local control on survival","volume":"104","author":"Lee","year":"1994","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0355","first-page":"37","article-title":"Checkpoint inhibitors in treatment of metastatic mucosal melanoma","volume":"3","author":"Lian","year":"2014","journal-title":"Chin. Clin. Oncol."},{"issue":"Suppl","key":"10.1016\/j.critrevonc.2017.01.019_bib0360","article-title":"Phase II randomized study of high-dose interferon alfa-2b (HDI) versus chemotherapy as adjuvant therapy in patients with resected mucosal melanoma","volume":"30","author":"Lian","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.01.019_bib0365","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12105-012-0375-2","article-title":"Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population","volume":"6","author":"Liu","year":"2012","journal-title":"Head Neck Pathol."},{"issue":"11","key":"10.1016\/j.critrevonc.2017.01.019_bib0370","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1470-2045(12)70431-X","article-title":"Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial","volume":"13","author":"Long","year":"2012","journal-title":"Lancet Oncol."},{"issue":"20","key":"10.1016\/j.critrevonc.2017.01.019_bib0375","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","article-title":"Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma","volume":"371","author":"Long","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"9992","key":"10.1016\/j.critrevonc.2017.01.019_bib0380","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(15)60898-4","article-title":"Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial","volume":"386","author":"Long","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.critrevonc.2017.01.019_bib0385","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/014556139907800511","article-title":"Head and neck mucosal melanoma: a 32-year review","volume":"78","author":"Loree","year":"1999","journal-title":"Ear. Nose. Throat J."},{"issue":"7","key":"10.1016\/j.critrevonc.2017.01.019_bib0390","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/DAD.0000000000000035","article-title":"Head and neck mucosal melanoma: a review","volume":"36","author":"Louren\u00e7o","year":"2014","journal-title":"Am. J. Dermatopathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0395","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4193\/Rhin11.267","article-title":"Sinonasal malignant melanoma: an analysis of 115 cases assessing outcomes of surgery, postoperative radiotherapy and endoscopic resection","volume":"50","author":"Lund","year":"2012","journal-title":"Rhinology"},{"issue":"58","key":"10.1016\/j.critrevonc.2017.01.019_bib0400","first-page":"3627","article-title":"Human herpes virus DNA is rarely detected in non-UV light-associated primary malignant melanomas of mucous membranes","volume":"26","author":"Lundberg","year":"2006","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.01.019_bib0405","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/jop.12358","article-title":"Mutation scanning of BRAF,NRAS, KIT, and GNAQ\/GNA11 in oral mucosal melanoma: a study of 57 cases","volume":"45","author":"Lyu","year":"2016","journal-title":"J. Oral Pathol. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0410","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/jtbi.2001.2331","article-title":"The antimicrobial properties of melanocytes: melanosomes and melanin and the evolution of black skin","volume":"211","author":"Mackintosh","year":"2001","journal-title":"J. Theor. Biol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.01.019_bib0415","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.ejca.2011.10.004","article-title":"Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe","volume":"48","author":"Mallone","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0420","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4103\/0973-1482.136676","article-title":"Primary mucosal malignant melanoma of nasopharynx: a rare case report","volume":"10","author":"Mardi","year":"2014","journal-title":"J. Cancer Res. Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0425","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1470-2045(14)70012-9","article-title":"Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study","volume":"15","author":"McArthur","year":"2014","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0430","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/jso.10247","article-title":"Current management of mucosal melanoma of the head and neck","volume":"83","author":"Medina","year":"2003","journal-title":"J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2017.01.019_bib0435","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.joms.2006.10.044","article-title":"Oral malignant melanoma: the Amsterdam experience","volume":"65","author":"Meleti","year":"2007","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"12","key":"10.1016\/j.critrevonc.2017.01.019_bib0440","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/hed.20901","article-title":"Head and neck mucosal melanoma: experience with 42 patients, with emphasis on the role of postoperative radiotherapy","volume":"30","author":"Meleti","year":"2008","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0445","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hed.23298","article-title":"Sinonasal mucosal melanomas: the prognostic value of tumor classifications","volume":"36","author":"Michel","year":"2014","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.01.019_bib0450","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/apm.12529","article-title":"Mucosal malignant melanoma \u2013 a clinical, oncological, pathological and genetic survey","volume":"124","author":"Mikkelsen","year":"2016","journal-title":"APMIS"},{"issue":"5","key":"10.1016\/j.critrevonc.2017.01.019_bib0455","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/1078-0432.CCR-11-1987","article-title":"Sunitinib therapy for melanoma patients with KIT mutations","volume":"18","author":"Minor","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0460","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.radonc.2011.12.013","article-title":"Results of carbon ion radiotherapy for head and neck cancer","volume":"103","author":"Mizoe","year":"2012","journal-title":"Radiother. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2017.01.019_bib0465","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/jnci\/djq009","article-title":"Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis","volume":"102","author":"Mocellin","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0470","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/MOO.0b013e3283374d31","article-title":"Management of mucosal melanomas of the head and neck: did we make any progress?","volume":"18","author":"Moreno","year":"2010","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.01.019_bib0475","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/cncr.24976","article-title":"Mucosal melanoma of the nose and paranasal sinuses: a contemporary experience from the M.D. Anderson Cancer Center","volume":"116","author":"Moreno","year":"2010","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.01.019_bib0480","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hed.20785","article-title":"PNL2 melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the head and neck","volume":"30","author":"Morris","year":"2008","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.01.019_bib0485","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000163029","article-title":"Postoperative adjuvant radiation therapy in the treatment of primary head and neck mucosal melanomas","volume":"80","author":"Nakashima","year":"2008","journal-title":"ORL J. Otorhinolaryngol. Relat. Spec."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0490","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2273.1998.00099.x","article-title":"Mucosal melanoma of the head and neck","volume":"23","author":"Nandapalan","year":"1998","journal-title":"Clin. Otolaryngol. Allied Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0495","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2500\/ajr.2008.22.3170","article-title":"Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: a 10-year experience","volume":"22","author":"Nicolai","year":"2008","journal-title":"Am. J. Rhinol."},{"issue":"12","key":"10.1016\/j.critrevonc.2017.01.019_bib0500","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-10-2917","article-title":"KIT pathway alterations in mucosal melanomas of the vulva and other sites","volume":"17","author":"Omholt","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.critrevonc.2017.01.019_bib0505","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1158\/1078-0432.CCR-13-0143","article-title":"CTLA-4 and PD-1\/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients","volume":"19","author":"Ott","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0510","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0167-8140(86)80048-2","article-title":"Some factors of importance in the radiation treatment of malignant melanoma","volume":"5","author":"Overgaard","year":"1986","journal-title":"Radiother. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.01.019_bib0515","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/archotol.129.8.864","article-title":"The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region","volume":"129","author":"Owens","year":"2003","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.01.019_bib0520","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/CMR.0b013e32834b58cf","article-title":"Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors","volume":"21","author":"Papaspyrou","year":"2011","journal-title":"Melanoma Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0525","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hed.10019","article-title":"Primary mucosal malignant melanoma of the head and neck","volume":"24","author":"Patel","year":"2002","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.01.019_bib0530","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/01.mlg.0000217236.06585.a9","article-title":"Primary mucosal melanoma of head and neck: prognostic value of clear margins","volume":"116","author":"Penel","year":"2006","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.critrevonc.2017.01.019_bib0535","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1600-0625.2009.00912.x","article-title":"What are melanocytes really doing all day long\u2026?","volume":"18","author":"Plonka","year":"2009","journal-title":"Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.01.019_bib0540","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1634\/theoncologist.2012-0464","article-title":"Ipilimumab for patients with advanced mucosal melanoma","volume":"18","author":"Postow","year":"2013","journal-title":"Oncologist"},{"issue":"21","key":"10.1016\/j.critrevonc.2017.01.019_bib0545","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2017.01.019_bib0550","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/hed.20112","article-title":"Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck","volume":"26","author":"Prasad","year":"2004","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.critrevonc.2017.01.019_bib0555","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/cncr.20201","article-title":"Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, Stage I (lymph node-negative) tumors","volume":"100","author":"Prasad","year":"2004","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0560","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12105-011-0319-2","article-title":"Prognostic significance of regulators of cell cycle and apoptosis: p16(INK4a), p53, and bcl-2 in primary mucosal melanomas of the head and neck","volume":"6","author":"Prasad","year":"2012","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.critrevonc.2017.01.019_bib0565","series-title":"Information Network on Rare Cancers","author":"RARECAREnet","year":"2017"},{"issue":"7","key":"10.1016\/j.critrevonc.2017.01.019_bib0570","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1097-0142(19850401)55:7<1543::AID-CNCR2820550722>3.0.CO;2-F","article-title":"Primary malignant melanoma of the oral cavity. A review of 177 cases","volume":"55","author":"Rapini","year":"1985","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2017.01.019_bib0575","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S1470-2045(15)00083-2","article-title":"Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial","volume":"16","author":"Ribas","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0580","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00428-007-0524-2","article-title":"C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma","volume":"452","author":"Rivera","year":"2008","journal-title":"Virchows Arch."},{"issue":"26","key":"10.1016\/j.critrevonc.2017.01.019_bib0585","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Robert","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0590","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0595","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.01.019_bib0600","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0605","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0360-3016(93)90142-I","article-title":"The efficacy of radiation therapy for a malignant melanoma in the mucosa of the upper jaw: an analytic study","volume":"25","author":"Shibuya","year":"1993","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"10.1016\/j.critrevonc.2017.01.019_bib0610","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hed.21984","article-title":"Malignant melanoma of the head and neck: a multi-institutional retrospective analysis of cases in Northern Japan","volume":"34","author":"Shiga","year":"2012","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.critrevonc.2017.01.019_bib0615","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/archoto.2011.46","article-title":"Mucosal melanoma of the head and neck: predictors of prognosis","volume":"137","author":"Shuman","year":"2011","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.critrevonc.2017.01.019_bib0620","series-title":"TNM Classification of Malignant Tumours","year":"2009"},{"issue":"5","key":"10.1016\/j.critrevonc.2017.01.019_bib0625","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/01.cmr.0000222603.57932.b6","article-title":"Sentinel lymph node biopsy: a new perspective in head and neck mucosal melanoma?","volume":"16","author":"Starek","year":"2006","journal-title":"Melanoma Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0630","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2012.01.038","article-title":"Mapping of RBE-weighted doses between HIMAC- and LEM-Based treatment planning systems for carbon ion therapy","volume":"84","author":"Steinstr\u00e4ter","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"10.1016\/j.critrevonc.2017.01.019_bib0635","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.oraloncology.2012.01.019","article-title":"Treatment and prognosis of oral mucosal melanoma","volume":"48","author":"Sun","year":"2012","journal-title":"Oral Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.01.019_bib0640","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hed.23355","article-title":"Treatment and prognosis in sinonasal mucosal melanoma: a retrospective analysis of 65 patients from a single cancer center","volume":"36","author":"Sun","year":"2014","journal-title":"Head Neck"},{"issue":"9","key":"10.1016\/j.critrevonc.2017.01.019_bib0645","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jamaoto.2014.1321","article-title":"Endoscopic and open surgical approaches to locally advanced sinonasal melanoma: comparing the therapeutic benefits","volume":"140","author":"Swegal","year":"2014","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0650","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2014.03.031","article-title":"Update on primary mucosal melanoma","volume":"71","author":"Tacastacas","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0655","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0030-4220(94)90121-X","article-title":"Oral malignant melanoma in Japan","volume":"78","author":"Tanaka","year":"1994","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0660","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1368-8375(00)00107-X","article-title":"Expression of Rb: pRb2\/p130, p53, and p16 proteins in malignant melanoma of oral mucosa","volume":"37","author":"Tanaka","year":"2001","journal-title":"Oral Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.01.019_bib0665","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.joms.2004.01.017","article-title":"Clinical investigation of amelanotic malignant melanoma in the oral region","volume":"62","author":"Tanaka","year":"2004","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0670","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cncr.20775","article-title":"Postoperative radiotherapy for primary mucosal melanoma of the head and neck","volume":"103","author":"Temam","year":"2005","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0675","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.anl.2006.09.027","article-title":"Primary malignant melanoma of the larynx: a case report and literature review","volume":"34","author":"Terada","year":"2007","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0680","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1148\/radiol.11101821","article-title":"Diffusion-weighted MR imaging in the head and neck","volume":"263","author":"Thoeny","year":"2012","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.critrevonc.2017.01.019_bib0685","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00000478-200305000-00004","article-title":"Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system","volume":"27","author":"Thompson","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0690","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0039-6109(02)00100-7","article-title":"Mucosal melanomas","volume":"83","author":"Tomicic","year":"2003","journal-title":"Surg. Clin. North Am."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.01.019_bib0695","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hed.23079","article-title":"Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases","volume":"35","author":"Turri-Zanoni","year":"2013","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0700","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0266-4356(94)90172-4","article-title":"Primary malignant melanoma of the oral cavity\u2013its histological classification and treatment","volume":"32","author":"Umeda","year":"1994","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.01.019_bib0705","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ijrobp.2003.11.013","article-title":"A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan","volume":"59","author":"Wada","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0710","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/COC.0b013e318134ee88","article-title":"Mucosal melanoma of the head and neck","volume":"31","author":"Wagner","year":"2008","journal-title":"Am. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.01.019_bib0715","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.joms.2011.03.036","article-title":"Primary oral mucosal melanoma: advocate a wait-and-see policy in the clinically N0 patient","volume":"70","author":"Wang","year":"2012","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0720","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3315\/jdcr.2014.1175","article-title":"Melanoma of the oral cavity: pathogenesis, dermoscopy, clinical features, staging and management","volume":"8","author":"Warszawik-Hendzel","year":"2014","journal-title":"J. Dermatol. Case Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.01.019_bib0725","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial","volume":"16","author":"Weber","year":"2015","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.01.019_bib0730","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/hed.23761","article-title":"Prognostic value of S100\/CD31 and S100\/podoplanin double immunostaining in mucosal malignant melanoma of the head and neck","volume":"37","author":"Wermker","year":"2015","journal-title":"Head Neck"},{"issue":"18S","key":"10.1016\/j.critrevonc.2017.01.019_bib0735","article-title":"Markovicet SN al. Interferon-\u03b1 as adjuvant therapy for melanoma: an individual patient data meta-analysis of randomised trials","volume":"25","author":"Wheatley","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0740","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1148\/radiology.165.1.3628773","article-title":"Intracerebral malignant melanoma: high-field-strength MR imaging","volume":"165","author":"Woodruff","year":"1987","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.critrevonc.2017.01.019_bib0745","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.oraloncology.2014.01.008","article-title":"Neck dissection for oral mucosal melanoma: caution of nodular lesion","volume":"50","author":"Wu","year":"2014","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0750","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijrobp.2008.07.056","article-title":"Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy","volume":"74","author":"Yanagi","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0755","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/CMR.0b013e3283457743","article-title":"Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma: multicenter, retrospective analysis in Asia","volume":"21","author":"Yi","year":"2011","journal-title":"Melanoma Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0760","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00004728-199805000-00024","article-title":"MRI of mucosal malignant melanoma of the head and neck","volume":"22","author":"Yoshioka","year":"1998","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"7","key":"10.1016\/j.critrevonc.2017.01.019_bib0765","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamaoto.2013.3424","article-title":"Subglottic presentation of a rare tumor: primary or metastatic? Primary mucosal melanoma of the subglottic larynx","volume":"139","author":"Zaghi","year":"2013","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.01.019_bib0770","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/bjc.2013.373","article-title":"NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases","volume":"109","author":"Zebary","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.01.019_bib0775","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijrobp.2010.04.071","article-title":"Proton beam therapy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study","volume":"81","author":"Zenda","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817300458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817300458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T08:57:39Z","timestamp":1719046659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842817300458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":155,"alternative-id":["S1040842817300458"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.01.019","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosal melanoma of the head and neck","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}